Phase II study of trifluridine/tipiracil in metastatic breast cancers with or without prior exposure to fluoropyrimidines. Lim JSJ, Ow SGW, Wong ALA, Lee MXW, et al. Eur J Cancer 2023;193:113311.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Lim JSJ, Ow SGW, Wong ALA, Lee MXW, et al. Phase II study of trifluridine/tipiracil in metastatic breast cancers with or without prior exposure to fluoropyrimidines. Eur J Cancer 2023;193:113311.
PMID: 37717281